Stifel Financial’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Other funds holding VYGR
AC
VPC
EAM
EC
Stifel Financial's VYGR Position: Q3 2025 in Review
Stifel Financial sold out of Voyager Therapeutics (VYGR) in Q3 2025, closing a stake of 20,200 shares — an estimated $62.8K sold.
Stifel Financial first reported a position in VYGR in Q4 2017 and held it in 19 quarters. The position peaked at $723K in Q2 2019. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.
- Stifel Financial reported no remaining Voyager Therapeutics position as of Q3 2025 after selling out during the quarter.
- Stifel Financial sold 20,200 Voyager Therapeutics shares in Q3 2025, an estimated $62.8K.
- Stifel Financial first reported a position in Voyager Therapeutics in Q4 2017 and held it in 19 quarters.
- Stifel Financial's Voyager Therapeutics position peaked at $723K in Q2 2019.
- 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.
Based on Stifel Financial's 13F filing for Q3 2025, filed 12 Nov 2025.